$0.88
0.11% day before yesterday
Nasdaq, Sep 06, 10:00 pm CET
ISIN
US59503A1051
Symbol
MBOT
Sector
Industry

Microbot Medical Inc Stock price

$0.88
-0.08 8.57% 1M
-0.43 33.12% 6M
-0.76 46.58% YTD
-1.26 59.06% 1Y
-6.46 88.06% 3Y
-6.18 87.59% 5Y
-2,380.52 99.96% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
-0.00 0.11%
ISIN
US59503A1051
Symbol
MBOT
Sector
Industry

Key metrics

Market capitalization $14.46m
Enterprise Value $8.10m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 2.31
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-9.51m
Free Cash Flow (TTM) Free Cash Flow $-7.89m
Cash position $6.51m
EPS (TTM) EPS $-0.81
Short interest 1.10%
Show more

Is Microbot Medical Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Microbot Medical Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Microbot Medical Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Microbot Medical Inc:

Buy
100%

Financial data from Microbot Medical Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
- -
-
100%
- Direct Costs 0.10 0.10
9% 9%
-
-0.10 -0.10
9% 9%
-
- Selling and Administrative Expenses 4.06 4.06
16% 16%
-
- Research and Development Expense 5.25 5.25
22% 22%
-
-9.41 -9.41
19% 19%
-
- Depreciation and Amortization 0.10 0.10
9% 9%
-
EBIT (Operating Income) EBIT -9.51 -9.51
19% 19%
-
Net Profit -10 -10
10% 10%
-

In millions USD.

Don't miss a Thing! We will send you all news about Microbot Medical Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Microbot Medical Inc Stock News

Neutral
GlobeNewsWire
16 days ago
The agreement follows the successful completion of Phase 1 which evaluated the viability of LIBERTY as a remote telesurgery platform
Neutral
GlobeNewsWire
25 days ago
The ISO 13485 certification is a validation of the Company's robust quality system The ISO 13485 certification is a validation of the Company's robust quality system
Neutral
GlobeNewsWire
about one month ago
The evaluation phase will explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system The evaluation phase will explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system
More Microbot Medical Inc News

Company Profile

Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

Head office United States
CEO Harel Gadot
Employees 22
Founded 1988
Website microbotmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today